Preventing Exercise Resistance With Sedentary Interruptions
PERSI
1 other identifier
interventional
24
1 country
1
Brief Summary
The goal of this randomised cross-over trial is to learn about the interaction between sedentary behaviour throughout the day and the metabolic effect of an exercise bout on that same day in office workers with an increased risk for chronic disease. The main question this study aims to answer is if the lipid-lowering effects of an exercise bout can be more pronounced by implementing alternations between a seated and a standing working position throughout the day. Participants will be asked to:
- Complete three intervention periods for a duration of 2 days at their workplace,
- Attend a supervised training session (60min) at the research facility at the end of each intervention period,
- Attend three assessment days at the research facility where postprandial metabolism will be evaluated after a standardised meal test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2024
CompletedStudy Start
First participant enrolled
February 19, 2024
CompletedFirst Posted
Study publicly available on registry
February 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMarch 4, 2024
March 1, 2024
8 months
February 19, 2024
March 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total and incremental area under the curve of postprandial response in lipid metabolism
Lipid levels will be assessed at nine different timepoints (0 minutes, 30 minutes, 60 minutes, 120 minutes, 180 minutes, 210 minutes, 240 minutes, 300 minutes and 360 minutes). Postprandial responses will be defined as the area under the curve (AUC) over the three-hour period after each test meal and the cumulative AUC of the whole time frame.
360 minutes
Secondary Outcomes (2)
Total and incremental area under the curve of glucose and insulin postprandial responses
360 minutes
Resting metabolic rate
0 minute
Study Arms (3)
Exercise after prolonged sitting (SIT)
ACTIVE COMPARATORAll participants will be instructed to complete two working days (8h) where they perform seated desk-work throughout the day. At the end of the second day, they will perform a supervised exercise bout at the research facility.
Exercise after sitting with standing breaks (WBR)
EXPERIMENTALAll participants will be instructed to complete two working days (8h) where they alternate seated desk-work with standing desk-work hourly throughout the day. At the end of the second day, they will perform a supervised exercise bout at the research facility.
Non-exercise control (NEX)
OTHERIn this control group all participants will be instructed to complete two working days (8h) where they perform seated desk-work throughout the day.
Interventions
A mobile sit-to-stand desk will be installed at the workplace and participants are instructed to alternate their working position every 30 minutes during two working days (8h).
Participants will perform a continuous aerobic exercise bout for a duration of 60 minutes at a moderate intensity, which is defined as 60% of their maximal oxygen uptake (VO2max).
Participants are instructed to minimise any behaviour that is not sedentary during two working days (8h).
Eligibility Criteria
You may qualify if:
- between 30 and 65 years old,
- primarily work in an office environment for at least 0.75 full time equivalents,
- sedentary (on average \>9h of sedentary time per day, assessed objectively),
- at an increased risk for disturbances in lipid profile (assessed with fingerstick (Analox®) total cholesterol \>200 mg/dL or fingerstick triglycerides \>150 mg/dL),
- written informed consent to participate in the study.
You may not qualify if:
- medical conditions precluding physical activity (PA) participation,
- abusive alcohol intake (\>20 units/week),
- pregnant or intention to become pregnant,
- change in dietary habits or weight loss (\>2kg) in the last month before the study,
- a diagnosis of cardiometabolic diseases such as diabetes mellitus or cardiovascular diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hasselt University
Diepenbeek, Limburg, 3590, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bert Op 't Eijnde, Prof. dr.
Hasselt University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessor will be blinded to the allocation of participants as samples will be code labeled.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 19, 2024
First Posted
February 26, 2024
Study Start
February 19, 2024
Primary Completion
October 30, 2024
Study Completion
July 1, 2025
Last Updated
March 4, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- After publication of the results, data will become available for a duration of 25 years.
- Access Criteria
- Access will be granted after motivated and reasonable request to the principal investigator.
In a restriced access depositry. Personal data is sensitive data and is thus protected in a restricted access repository. During the project these data will be pseudonymized and after completion of the project data will be anonymized and the pseudonymization key will be destroyed. Access can be granted by the primary investigator who holds the pseudonymization key in a restricted folder during the project.